The company expired its plan on September 10, 2015.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3,020 JPY | +0.97% | +3.85% | +28.40% |
06-26 | Towa Pharmaceutical Issues Shares as Restricted Compensation to Directors | MT |
06-06 | Luye Pharma's Japanese Partner Towa Files New Drug Application for Dementia Patch | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.40% | 911M | |
+54.07% | 816B | |
+38.59% | 634B | |
-7.05% | 351B | |
+15.44% | 323B | |
+5.72% | 293B | |
+13.40% | 238B | |
+0.61% | 222B | |
+13.24% | 218B | |
+7.42% | 167B |
- Stock Market
- Equities
- 4553 Stock
- News Towa Pharmaceutical Co., Ltd.
- Towa Pharmaceutical Co., Ltd.'s Equity Buyback announced on July 7, 2015, has expired with repurchase of 592,000 shares, representing 3.48% for ¥4,999.53 million.